Lumbar ESPB in Hip Replacement Surgery
CompletedNot applicableNCT06282666
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study, continuous erector spinae plane block (ESPB) will be compared to continuous epidural analgesia in patients undergoing elective hip replacement surgery. Opioid consumption, pain severity, quadriceps femoris muscle strength, ability to walk, and quality of recovery will be evaluated. Moreover, chronic pain severity in months after the hospital discharge will be assessed.
Study details
- Official title
- Comparison of Continuous Lumbar Erector Spinae Plane Block to Continuous Epidural Analgesia in Patients Undergoing Hip Replacement Surgery
- Conditions
- Interventions
- Procedure: Spinal anesthesia
- Procedure: lumbar erector spinae plane block
- Procedure: Epidural analgesia
- Procedure: patient-controlled analgesia
- Diagnostic test: Timed Up and Go test
- Diagnostic test: neuropathic pain symptom inventory
- Diagnostic test: Lovett test
- Diagnostic test: Visual analog scale
- Diagnostic test: Quality of Recovery 40
- Diagnostic test: Ability to sit, stand upright, and walk
- Sponsor
- Medical University of Lublin
- Start date
- 2024-02-19
- Primary completion
- 2025-02-01
- Sex
- All
- Age range
- from 18 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * primary hip replacement surgery due to coxarthrosis * anesthetized with spinal technique * able to use PCA pump * having access to phone Exclusion Criteria: * patients taking painkillers not related to coxarthrosis; * having active cancer, * dementia or challenging contact with the patient; * suffering from depression or other psychiatric disorders that required antidepressant treatment; * consuming alcohol or recreational drug addiction; * contraindications to the regional block.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06282666